Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07178210 · ClinicalTrials.gov registry record · NA
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
A NA study of Alzheimer Disease and Lymphatic Obstruction, sponsored by MMI (Medical Microinstruments, Inc.).
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07178210: Recruiting NA study of Alzheimer Disease and Lymphatic Obstruction, sponsored by MMI (Medical Microinstruments, Inc.).
NCT07178210 is a NA study of Alzheimer Disease and Lymphatic Obstruction that is actively recruiting participants, run by MMI (Medical Microinstruments, Inc.). The registered enrollment target is 15 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07178210, a NA study of Alzheimer Disease and Lymphatic Obstruction, is actively recruiting participants, sponsored by MMI (Medical Microinstruments, Inc.).
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
Primary Outcome
All intraoperative and postoperative device-related serious adverse events (SAEs) will be captured from the start of the index procedure through 30 days post-index procedure for each participant. The device-related SAE rate will be reported at 30 days post-index procedure for all evaluable participants.
Conditions Studied
Interventions
- DEVICE Symani Surgical System
Study Locations (1)
Florida
- Baptist Health Research Institute - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT07178210 shows while recruiting
NCT07178210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Symani Surgical System is the first listed.
NCT07178210 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07178210 about?
NCT07178210 is a clinical study titled "Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease". The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
What is the current status of trial NCT07178210?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-03-31. Estimated completion is 2027-08-31.
What conditions does trial NCT07178210 study?
This clinical trial studies the following conditions: Alzheimer Disease, Lymphatic Obstruction.
What interventions are being tested in trial NCT07178210?
The interventions under investigation include: Symani Surgical System (DEVICE).
Who is sponsoring clinical trial NCT07178210?
This trial is sponsored by MMI (Medical Microinstruments, Inc.), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07178210 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07178210's enrollment target sits among peer trials
15 279th of 306 higher than 24 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI